• Sign In
  • Sign Up
  • Sign In
  • Sign Up
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics and Gynecology
  • Otolaryngology
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics and Gynecology
  • Otolaryngology
ADA 85th Scientific Sessions ’25

Age at Type 2 Diabetes Diagnosis and Mortality and Cardiovascular Risks, and Years of Life Lost in South Asians

This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in

Read More »
July 17, 2025
ADA 85th Scientific Sessions ’25

The Significant Reduction in Epicardial Adipose Tissue Thickness after Dapagliflozin Treatment Is Preserved and Even Increased after Four Years—The DAPAHEART Four- Year Follow-up Study

This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in

Read More »
July 16, 2025
ADA 85th Scientific Sessions ’25

Dapagliflozin Alters TCA Cycle Activation during Insulin Withdrawal in T1D Patients

This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in

Read More »
July 15, 2025
ADA 85th Scientific Sessions ’25

A Four-Week Treatment with Dapagliflozin Reduces Insulin- Stimulated Renal Glucose Uptake

This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in

Read More »
July 11, 2025
ADA 85th Scientific Sessions ’25

Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Dual GLP- 1/GIP Receptor Agonist (HDM1005)—A Phase I, Randomized, Double- Blind, Placebo- Controlled, Single and Multiple Dose- Escalation Study

This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in

Read More »
July 10, 2025
ADA 85th Scientific Sessions ’25

Sustained Weight Reduction by Thresholds in Adults with Obesity and Prediabetes Treated with Tirzepatide over 176 Weeks (SURMOUNT-1)

This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in

Read More »
July 9, 2025
« Previous Page1 Page2 Page3 Next »
Latest Conferences
  • Uncovering the Neurological Substrates Underlying Restlessness in Cluster Headache – A Functional MRI Study
  • Screening Visuospatial and Executive Function in People with Epilepsy
  • Mayo Clinic Pilot Study Suggests Rimegepant May Benefit Some Cluster Headache Patients
  • Uncovering the Neurological Substrates Underlying Restlessness in Cluster Headache – A Functional MRI Study
  • Cracking the Code on Small Fiber Neuropathy: Skin Biopsies Reshape Diagnosis of Chronic Pain Conditions
Societies
  • ACC: American College of Cardiology
  • ADA: American Diabetes Association
  • ASN: American Society of Nephrology
  • BAD: British Association of Dermatologists
  • ERA EDTA: European Renal Association – European Dialysis and Transplant Association
  • ESC: European Society of Cardiology
  • ISN: International Society of Nephrology
  • WCPD: World Congress of Pediatric Dermatology
  • AHA: American Heart Association
  • AAD: American Association of Dermatology
  • ASN: American Society of Nephrology
  • WTC: World Trichology Conference
  • AAO-HNS: American Academy of Otolaryngology–Head and Neck Surgery
Speciality
  • Cardiology
  • Endocrinology
  • Nephrology
  • Neurology
  • Dermatology
  • Obstetrics & Gynecology
  • Respiratory
  • Otolaryngology
Tags
AACE ACC ADA AHA ASN BAD ERA ESC ISN ISN-WCN 2021 Kidney Week 2020 SCAI WCPD wcpn

© All rights reserved.